Aileron Therapeutics, Inc. (ALRN)
NASDAQ: ALRN · Real-Time Price · USD
4.080
+0.060 (1.49%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Aileron Therapeutics Market Cap
Aileron Therapeutics has a market cap or net worth of $88.40 million as of October 29, 2024. Its market cap has increased by 1,450.82% in one year.
Market Cap
88.40M
Enterprise Value
111.48M
1-Year Change
1,450.82%
Ranking
Category
Stock Price
$4.08
Market Cap Chart
Since June 29, 2017, Aileron Therapeutics's market cap has decreased from $158.90M to $88.40M, a decrease of -44.37%. That is a compound annual growth rate of -7.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2024 | 87.10M | 531.16% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CASI Pharmaceuticals | 92.32M |
| InflaRx | 92.15M |
| HilleVax | 91.15M |
| BeyondSpring | 89.37M |
| Eupraxia Pharmaceuticals | 88.42M |
| Protalix BioTherapeutics | 86.04M |
| MediciNova | 85.83M |
| Coherus BioSciences | 85.65M |